Cell Source, Inc. (CLCS) Stock & Financials
Cell Source, Inc. (CLCS) is a company.
What to check next
For informational purposes only. Not investment advice. Data may be delayed or inaccurate; verify independently. The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results. Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing.
Cell Source, Inc. Financial Health ScoreFY2014
Weak financial health; requires careful evaluation
This Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data Highlights
- Altman Z-Score -77.49 (distress zone, below 1.23 threshold)
- Piotroski F-Score: 1/9 criteria passed
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
About Cell Source, Inc.
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Profitability Data Under ReviewProfitability metrics are being verified. Some SEC filing data may require additional validation.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Balance Sheet Data LimitedInsufficient data to assess financial health.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
Cell Source, Inc. 1-Year Revenue, Profit & Cash Flow History
Annual Financials
FY2014| Metric | FY2014 |
|---|---|
| Revenue | $0 |
| Net Income | $-4,057,479 |
| Total Assets | $123,105 |
| Total Debt | - |
| Total Equity | $-3,783,728 |
| Profit Margin | - |
| ROE | - |
| ROA | -3295.9% |
Insider Trading
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
Cell Source, Inc. Free Cash Flow & Dividend Coverage
Cash Flow History
FY2014| Metric | FY2014 |
|---|---|
| Operating CF | -$3.1M |
| CapEx | -$2,582 |
| Free Cash Flow | -$3.1M |
| FCF Margin | - |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
Cell Source, Inc. Risk Factors
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
Cell Source, Inc. FAQ
Does Cell Source, Inc. pay dividends?
No, Cell Source, Inc. (CLCS) does not currently pay dividends to shareholders.
What is Cell Source, Inc.'s financial health score?
Cell Source, Inc. has a financial health score of 16/100 (Grade: F), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of Cell Source, Inc. financial data are available?
1 years of financial data are available for Cell Source, Inc. from FY2014 to FY2014. All figures are compiled from SEC EDGAR 10-K filings.